Buy JSW Energy, Biocon: Hemant Thukral

Hemant Thukral of Aditya Birla Money told CNBC-TV18, "We have selected two midcaps because as expected midcaps are expected to outperform. One of them will be JSW Energy. After a long time we saw 91 percent positions got rolled virtually after four series we saw that rollover happening. Yesterday, we saw 6 percent fresh open interest added up. 79 lakh shares traded on the cash front which is double of the average of last five days if I see cash volumes, the stock has managed to cross that Rs 63-64 band. So, now we will recommend a buy keeping a stop loss of Rs 63.50 and expect a target of Rs 68 to come in next two-three trading sessions.""The second midcap stock is midcap pharma, Biocon. We have seen all pharma companies attract buying interest yesterday but Biocon in particular has attracted 9 percent long positions. What was interesting was the way the 1,100 Put writers were adding positions which is clearly telling me that now the new support is Rs 1,090-1,095. So that one should keep as a stop loss and we expect Rs 1,150-1,170 zone tested for Biocon in a very short-term period which is in the next two-three trading sessions," he said."So JSW Energy and Biocon are the two stocks we have selected and we expect them to do good in coming few sessions."